Literature DB >> 18583061

The kisspeptin (KiSS-1)/GPR54 system in cancer biology.

Angeliki Makri1, Nikolaos Pissimissis, Peter Lembessis, Constantine Polychronakos, Michael Koutsilieris.   

Abstract

Kisspeptin (KiSS-1) gene, initially described as a melanoma metastasis suppressor gene, encodes a number of peptides (kp-54, kp-14, kp-13, kp-10), which are endogenous ligands to a G protein-coupled receptor, referred as hOT7T175 or AXOR12 or GPR54. So far intensive investigation has provided substantiate evidence supporting the role of KiSS-1/GPR54 system in cancer biology as well as in the regulation of the reproductive function and trophoblast invasion. The precise mechanism by which KiSS-1/GPR54 system is affecting cancer cell growth and metastasis includes complex endocrine, paracrine and autocrine actions. Nevertheless, the detail mechanism of such actions is still under intensive investigation. Herein we review the evidence which support the role of KiSS-1/GPR54 system in cancer biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583061     DOI: 10.1016/j.ctrv.2008.05.007

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  26 in total

Review 1.  Kisspeptin signalling in the physiology and pathophysiology of the urogenital system.

Authors:  Fazal Wahab; Bibi Atika; Muhammad Shahab; Rüdiger Behr
Journal:  Nat Rev Urol       Date:  2015-12-01       Impact factor: 14.432

2.  Metastin is not involved in metastatic potential of non-small cell lung cancer.

Authors:  Eleni M Karapanagiotou; Kalliopi D Dilana; Ioannis Gkiozos; Ioannis Gratsias; Sotirios Tsimpoukis; Aris Polyzos; Kostas N Syrigos
Journal:  Med Oncol       Date:  2010-03-06       Impact factor: 3.064

3.  Q36R polymorphism of KiSS-1 gene in Brazilian head and neck cancer patients.

Authors:  Mariângela Torreglosa Ruiz; Ana Lívia Silva Galbiatti; Erika Cristina Pavarino; José Victor Maniglia; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2012-01-01       Impact factor: 2.316

4.  Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patients.

Authors:  Martha Stathaki; Athanasios Armakolas; Andreas Dimakakos; Loukas Kaklamanis; Ioannis Vlachos; Manoussos M Konstantoulakis; George Zografos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-03-18       Impact factor: 6.354

5.  KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients.

Authors:  Virginia Cebrian; Marta Fierro; Esteban Orenes-Piñero; Laura Grau; Patricia Moya; Thorsten Ecke; Miguel Alvarez; Marta Gil; Ferran Algaba; Joaquin Bellmunt; Carlos Cordon-Cardo; James Catto; Antonio López-Beltrán; Marta Sánchez-Carbayo
Journal:  Am J Pathol       Date:  2011-06-17       Impact factor: 4.307

6.  Decrease in hypothalamic Kiss1 and Kiss1r expression: a potential mechanism for fasting-induced suppression of the HPG axis in the adult male rhesus monkey (Macaca mulatta).

Authors:  F Wahab; F Ullah; Y-M Chan; S B Seminara; M Shahab
Journal:  Horm Metab Res       Date:  2010-12-10       Impact factor: 2.936

7.  Differential regulation of GPR54 transcription by specificity protein-1 and partial estrogen response element in mouse pituitary cells.

Authors:  Mia C DeFino; Jennifer L Wacker; John S Lyssand; Edith H Wang; Chris Hague
Journal:  Biochem Biophys Res Commun       Date:  2010-02-10       Impact factor: 3.575

8.  KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.

Authors:  Marianna Yaron; Ulrich Renner; Suzan Gilad; Günter K Stalla; Naftali Stern; Yona Greenman
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

9.  Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1.

Authors:  Eric D Young; Kyle Strom; Ashley F Tsue; Joseph L Usset; Seth MacPherson; John T McGuire; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2018-03-26       Impact factor: 5.150

10.  A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10.

Authors:  Annette E Curtis; Jennifer H Cooke; Jordan E Baxter; James R C Parkinson; Attia Bataveljic; Mohammad A Ghatei; Stephen R Bloom; Kevin G Murphy
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.